series-b
Stage
2021
Founded
2
Investors
About
NeUmiRNa Therapeutics develops microRNA-based therapies aimed at treating neurological diseases such as epilepsy and Parkinson’s by restoring healthy neural network function.
Explore NeUmiRNa Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.